Six proteins differentially expressed between luminal A samples in COCA cluster 1 versus COCA cluster 4. (PDF 771 kb
Background: Breast cancer is a heterogeneous disease at the clinical and molecular level. In this st...
Background: Breast cancer is a heterogeneous disease at the clinical and molecular level. In this st...
ToppGene GOEA based on heatmap gene clusters, internal cohort (1843 probes) and external cohorts (45...
P-values and statistics from analysis of variance identifying the top 500 pathway entities defining ...
Oslo2 tumors sorted according to membership of each of seven PARADIGM clusters (columns) with heatma...
Figure S2. t-SNE plots showing subtype clustering of Luminal A cases in the TCGA cohort according to...
Table S1. Top ten genes ranked by differences in gene expression between Tertile 1 (pure) and Tertil...
Background Breast cancer is a heterogeneous disease at the clinical and molecular level. In this stu...
Table S3. Molecular characteristics of Luminal A breast cancers in the TCGA cohort classified by sub...
Abstract Background Breast cancer is a heterogeneous disease at the clinical and molecular level. In...
Figure S1. t-SNE plots for all subtypes in the TCGA cohort, showing: 1) luminal subtypes cluster rel...
Tables S4. Most differentially expressed proteins between LumA, HER2-positive, and TN/basal-like bre...
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Table S2. Clinical characteristics of patients in the TCGA cohort with Luminal A breast cancer, clas...
Tumor vs Adjacent 4 gene signatures. The 4 non-joint 41-gene signatures are included, each consistin...
Background: Breast cancer is a heterogeneous disease at the clinical and molecular level. In this st...
Background: Breast cancer is a heterogeneous disease at the clinical and molecular level. In this st...
ToppGene GOEA based on heatmap gene clusters, internal cohort (1843 probes) and external cohorts (45...
P-values and statistics from analysis of variance identifying the top 500 pathway entities defining ...
Oslo2 tumors sorted according to membership of each of seven PARADIGM clusters (columns) with heatma...
Figure S2. t-SNE plots showing subtype clustering of Luminal A cases in the TCGA cohort according to...
Table S1. Top ten genes ranked by differences in gene expression between Tertile 1 (pure) and Tertil...
Background Breast cancer is a heterogeneous disease at the clinical and molecular level. In this stu...
Table S3. Molecular characteristics of Luminal A breast cancers in the TCGA cohort classified by sub...
Abstract Background Breast cancer is a heterogeneous disease at the clinical and molecular level. In...
Figure S1. t-SNE plots for all subtypes in the TCGA cohort, showing: 1) luminal subtypes cluster rel...
Tables S4. Most differentially expressed proteins between LumA, HER2-positive, and TN/basal-like bre...
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Table S2. Clinical characteristics of patients in the TCGA cohort with Luminal A breast cancer, clas...
Tumor vs Adjacent 4 gene signatures. The 4 non-joint 41-gene signatures are included, each consistin...
Background: Breast cancer is a heterogeneous disease at the clinical and molecular level. In this st...
Background: Breast cancer is a heterogeneous disease at the clinical and molecular level. In this st...
ToppGene GOEA based on heatmap gene clusters, internal cohort (1843 probes) and external cohorts (45...